Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chart: Sen. Hatch Has Seven Questions About FDA's Structure And Resources

Executive Summary

Sen. Orrin Hatch, R-Utah, concluded his speech at the FDA/Food and Drug Law Institute's Annual Meeting on April 22 by asking the audience a series of questions. Some were clearly rhetorical; others emphasized his affection for the dietary supplement industry, but the list highlights what one of the health arena's more powerful actors believes are the thorniest issues facing FDA at the moment. "All of you need to think long and hard about the answers to these questions," Hatch told the audience. "That being said, this is not a test." Below is a transcript of the remarks, with the topic of the questions bolded.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS050984

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel